Enter your email Address

Eyevensys Eyevensys Eyevensys Eyevensys
  • About
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • EYS606
  • Pipeline
    • Our Pipeline
    • EYS809
    • EYS611
  • News
    • Press Releases
    • In the Media
    • Events
    • Scientific Publications
  • Investors
  • Contact
Eyevensys

Next Generation Ophthalmic Drug Delivery Summit

January 26
Loading Events
  • This event has passed.

President and CEO, Patricia Zilliox, PhD, is presenting at the following: Next Generation Ophthalmic Drug Delivery Summit:

https://ter.li/vs5ekf

  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live

Details

Date:
January 26
Recent Posts
  • Nonviral Platforms Streamline Gene Therapy Delivery
  • Eyevensys Announces Positive Preclinical Data Demonstrating Superiority of EYS809 over Aflibercept for Wet Age-Related Macular Degeneration (AMD) at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
  • ARVO 2023: Eyevensys announces positive preclinical data demonstrating efficacy of EYS809 over aflibercept for wet AMD
  • Eyevensys Recaps Highlights from Investigator Meeting and Presentations at the ARVO 2022 Annual Conference   
  • Eyevensys to present at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting
OIS Retina San Antonio Conference
Oracles of Eye Innovation

About Us
Meet the Team
Technology
Pipeline

Contact Us
Scientific Publications
Press Releases
Events

Cookie Policy
Privacy Policy

© 2023 Eyevensys. All rights reserved.

  • About
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • EYS606
  • Pipeline
    • Our Pipeline
    • EYS809
    • EYS611
  • News
    • Press Releases
    • In the Media
    • Events
    • Scientific Publications
  • Investors
  • Contact
Start Typing